RxDoctor Payments DataLook up a doctor →

Rose-Elyse Snelson, PA

Physician Assistant · Hendersonville, TNNPI 1912652694

Payments from drug & device makers

$11,963in general payments, 2019–2025

Across 568 payments — averaging $21.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • UCB, Inc.$1K
  • Jazz Pharmaceuticals Inc.$1K
  • Neurelis, Inc.$951
  • Lundbeck LLC$861
  • SK Life Science, Inc.$629
  • plus $6K from 37 others

What the payments were for

  • Food & beverage$11,962100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,963 in reported general payments places this provider in the 95th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$15,079
Medicare patients
83
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant21$34,193
Trokendi XrTopiramate18$26,209
Nurtec OdtRimegepant Sulfate12$19,155
NayzilamMidazolam14$17,641
NuedextaDextromethorphan Hbr/Quinidine14$15,181
XcopriCenobamate14$14,975
QuliptaAtogepant11$13,649
VimpatLacosamide12$13,063
Emgality PenGalcanezumab-Gnlm13$11,109
Levetiracetam ErLevetiracetam56$3,400
Levetiracetam99$2,736
Primidone67$1,738
Lacosamide18$1,639
Memantine Hcl119$1,481
Carbidopa-LevodopaCarbidopa/Levodopa56$1,388

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta$1,240$47,84232 claims
UCB, Inc.Nayzilam, Vimpat$1,198$30,70426 claims
Supernus Pharmaceuticals, Inc.Trokendi Xr$389$26,20918 claims
PfizerNurtec Odt$582$19,15512 claims
SK Life Science, Inc.Xcopri$629$14,97514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Hendersonville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →